A team that included RPB-supported researchers at Tufts University School of Medicine has successfully prevented corneal inflammation, a condition that contributes to corneal tissue transplantation rejection, by inhibiting the overgrowth of lymphatic vessels.
The findings, published in Nature Communications, may have wider impact because the same overgrowth of lymphatic vessels, called Lymphangiogenesis, occurs in organ transplant rejection, cancer metastasis, lymphatic obstruction, complications of diabetes and hypertension.
April 13, 2016
The ARPA-H THEA project takes on an exciting challenge.
The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, retinal diseases, and many more.
Leaders of organizations that fund vision research convene in Washington, D.C. to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |